Dr. Suzanne Hagler and colleagues from Cincinnati Children's Hospital Medical Center presented the news that a high percentage of children and adolescents with migraines seem to suffer from a small, but possibly significant, lack of CoQ10, vitamin D and vitamin B2.
Dr. Hagler's study relied on information from a database of patients with migraine that had additional data from blood tests of the content of vitamin D, riboflavin, folate and coenzyme Q10.
Most participants in the study took some preventive migraine medication and a few took vitamin supplements. Based on the available evidence, the researchers were not able to conclude with sufficient certainty that continued supplementation with these drugs would be beneficial against migraine attacks. Further research is needed, they conclude.
What they found was, that more females (both girls and young women) than males (boys and young men) experienced a lack of coenzyme Q10 at baseline. Boys and young men were more likely to suffer from vitamin D deficiency. It was unclear whether there was folate deficiency. Patients with chronic migraine were more likely to be lacking coenzyme Q10 and riboflavin than those with so-called episodic migraine.
You can find good research results on all the nutrients mentioned above for those experiencing migraines.
Research on vitamin D’s role in migraine has been inconsistent with some studies showing a positive association and others showing no association. However, a high vitamin D level might reduce inflammation and in this way help reduce the symptoms.
CoQ10 and riboflavin are both part of the body's energy metabolism and have in a number of earlier scientific studies proved effective in the treatment of migraine.
In a small, controlled study from 1998, 55 migraine patients received high doses of riboflavin (400 mg daily) for three months, an amount which far exceeds the RDA. The study showed that over half of the participants achieved more than a 50% improvement in their symptoms. The study also showed that in general this dosage was well tolerated.
CoQ10 for Migraines
The substance CoQ10 stands out as the vitamin/vitamin-like substance that has previously been involved in most migraine research.
In 2002 we saw an open study in the journal Cephalalgia with 32 patients (26 women and 6 men), who suffered from migraine attacks with and without aura. They were all given 150 mg of CoQ10 daily. After three months of treatment, 61% of the participants experienced more than 50% fewer seizures.
In 2005 a double-blind study with 42 migraine patients was published in the journal Neurology showing that three months of treatment with 100 mg CoQ10 three times a day was superior to placebo with respect to frequency of attacks, days with headaches and nausea, and how well the preparations were tolerated.
47.6% of the patients receiving CoQ10 had more than 50% fewer attacks compared to 14.4% of the subjects receiving placebo. The researchers concluded from this that CoQ10 was effective and well tolerated.
In 2007 a study was published in the journal Headache. Scientists examined the presence of CoQ10 deficiency in patients with migraines and the potential effect of CoQ10 supplementation. 1,550 patients had their content of CoQ10 in the blood measured. These measurements showed that about one third of children and adolescents with migraines had either significant lack of Q10 or their CoQ10 level were below normal.
CoQ10 supplementation for a period of three months, reduced the frequency of seizures by 35%. The researchers concluded that it is possible to obtain “clinical improvement” of migraine with CoQ10 treatment.
Finally, in 2011 a double-blind study involving 120 children and adolescents suffering from migraine was published, which showed that a daily dose of 100 mg CoQ10 resulted in a statistically significant reduction in seizure frequency, -severity and duration during a four-week treatment with CoQ10.
Cincinnati Children's Hospital Medical Center 10.06.2016
Celikbileck, A. et al. Serum levels of vitamin D, vitamin D-binding protein and vitamin D receptor in migraine patients from central Anatolia region. Int J Clin Pract. 2014;68(10):1272-7.
Schoenen J, et al. Effectiveness of high-dose riboflavin in migraine prophylaxis. A randomized controlled trial. Neurology. 1998;50(2):466-70.
Rozen TD, et al. Open label trial of coenzyme Q10 as a migraine preventive. Cephalgia 2002;22(2):137-41.
Sándor PS, et al. Efficacy of coenzyme Q10 in migraine prophylaxis: a randomized controlled trial. Neurology 2005;64(4):713-5.
Hershey AD, et al. Coenzyme Q10 deficiency and response to supplementation in pediatric and adolescent migraine. Headache 2007;47(1):73-80.
Slater SK, et al. A randomized, double-blinded, placebo-controlled, crossover, add-on study of CoEnzyme Q10 in the prevention of pediatric and adolescent migraine. Cephalgia 2011;31(8):897-905.
Links to more in-depth information on this topic: